• Medicine
  • Published in Oncology 2009

In search of rigorous data on how to palliate the EGFR inhibitor-induced rash.

@article{Jatoi2009InSO,
  title={In search of rigorous data on how to palliate the EGFR inhibitor-induced rash.},
  author={Aminah Jatoi},
  journal={Oncology},
  year={2009},
  volume={23 2},
  pages={
          196, 198
        }
}
Epidermal growth factor receptor (EGFR) inhibitors have emerged as important drugs in cancer therapy, providing a proven survival advantage for some patients with non–small-cell lung cancer, colorectal cancer, head and neck cancer, and pancreas cancer.